Search Results - E. N. Basargina

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    DYSPLASIA OF THE HEART CONNECTIVE TISSUE AMONG CHILDREN by E.N. Basargina

    Published 2008-01-01

    Dysplasia of the heart connective tissue among children includes atrioventricular valve prolapse, abnormally positioned cords, aneurysms of the interatrial septum. Dysplasia of the heart connective tissue draws steadfast attention of the pediatricians due to the high population recurrence and risks,...

    Full description

    Get full text
    Article
  2. 2

    ALGLUCOSIDASE ALFA — A NEW STAGE IN THE THERAPY OF INFANTILE POMPE DISEASE by E. N. Basargina, E. N. Arkhipova, V. S. Ermolenko

    Published 2014-09-01

    Pompe disease is a rare severe hereditary disease caused by excessive glycogen storage in organs and target tissues due to the acid α-glucosidase gene mutation. Infantile and adult Pompe disease is characterized by involvement of cardiovascular, respiratory and muscular systems in the pathological p...

    Full description

    Get full text
    Article
  3. 3

    DYNAMICS OF MATRIX METALLOPROTEINASE CONCENTRATION DURING THE TREATMENT OF CHILDREN WITH DILATED CARDIOMYOPATHY’S EARLY DEBUT by A.S. Gasanov, E.N. Basargina, T.V. Bershova

    Published 2011-03-01

    The article shows the effectiveness of the complex treatment (angiotensin converting enzymes inhibitors, blockers, diuretics and cardiac glycosides) in children with dilated cardiomyopathy with an early debut. The dynamic observation of changes in morphological and functional cardiac parameters was...

    Full description

    Get full text
    Article
  4. 4

    DYNAMICS OF CARDIOVASCULAR SYSTEM PARAMETERS ON A BACKGROUND OF APPLICATION OF ADRENERGIC BLOCKERS IN CHILDREN WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY by E.A. Tikhomirova, O.O. Kupriyanova, E.N. Basargina, A.P. Ivanov

    Published 2007-10-01

    The article is dedicated to the issue of curing children with obstructive form of hypertrophic cardiomyopathy. It presents a complex evaluation of adrenergic blockers influence on the clinical finding, heart rate disorder and vegetative regulation of heart rate, as well as prognosis for patients wit...

    Full description

    Get full text
    Article
  5. 5

    STATE OF THE MATRIX METALLOPROTEINASES AND THEIR ROLE IN FORMATION OF THE CHRONIC HEART FAILURE IN CHILDREN WITH DILATED CARDIOMYOPATHY by E.N. Basargina, A.G. Gasanov, T.V. Bershova, M.I. Bakanov, A.P. Ivanov, O.O. Kupriyanova

    Published 2009-06-01

    The article is devoted to an important section of the pediatric cardiology — dilated cardiomyopathy (DCMP). This is largely due to the spread of the given disease, its possible progress and tendency to the formation of the chronic heart failure (CHF). The progress in the research of the DCMP'ac...

    Full description

    Get full text
    Article
  6. 6

    INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY by N. A. Berezneva, S. Yu. Nemtseva, O. E. Gromyko, N. S. Aver'yanova, N. D. Vashakhmadze, E. N. Basargina, V. G. Pinelis

    Published 2013-05-01

    Hypertrophic cardiomyopathy (HCMP) is a genetically determined myocardial disease, characterized by massive hypertrophy of the myocardium of the left and/or (rarely) the right ventricle, often associated with obstruction of the left ventricular outflow tract and diastolic dysfunction. The course of...

    Full description

    Get full text
    Article
  7. 7

    N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN by E. N. Arkhipova, I. V. Sil’nova, E. N. Basargina, I. V. Dvoryakovskii, A. B. Sugak, N. A. Mayanskii, M. K. Umarova

    Published 2012-10-01

    Non-compacted myocardium is a rare congenital cardiomyopathy. Due to the lack of uniform criteria, diagnostics of this condition is complicated presently, which results in over-diagnosing. N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of chronic cardiac insufficiency (CCI) in chil...

    Full description

    Get full text
    Article
  8. 8

    AMIODARONE THERAPY AIDED CHANGES IN THE THYROID GLAND FUNCTIONS AMONG THE CHILDREN by N.R. Belova, E.N. Arsen'eva, I.E. Sulaberidze, E.N. Basargina, G.M. Dvoriakovskaya, V.V. Botvin'eva, N.V. Malakhova

    Published 2006-12-01

    The results of research of thyroid condition and function in 82 children with dilated cardiomyopthy and arrhythmogenic dysfunction of myocardium without obvious thyropathy are submitted. Is shown that application of amiodaron results in induces predictable changes in thyroid function tests in 40% pa...

    Full description

    Get full text
    Article
  9. 9

    MAGNETIC RESONANCE IMAGING IN DIAGNOSING FIBROTIC AND CICATRICIAL HEART ALTERATIONS IN CHILDREN by L. S. Namazova-Baranova, V. I. Barskiy, V. E. Sinitsyn, E. N. Basargina, A. N. Getman, A. B. Sugak, I. V. Silnova, E. N. Arkhipova, A. K. Gevorkyan

    Published 2014-03-01

    The article provides an analysis of capabilities of magnetic resonance imaging with delayed contrast enhancement in diagnosing fibrotic alterations of varying severity. A hyperintense signal in the setting of myocardial delayed contrast enhancement programs indicates alterations of myocardial struct...

    Full description

    Get full text
    Article
  10. 10
  11. 11

    Molecular genetic features of the development of restrictive cardiomyopathy in Russian children by K. V. Savostyanov, E. N. Basargina, E. E. Ryabova, A. A. Pushkov, I. S. Zhanin, E. Yu. Basargina, A. Yu. Alekseeva, L. V. Muraveva, L. A. Gandaeva, A. P. Fisenko

    Published 2021-11-01

    Aim. To identify the proportion of restrictive cardiomyopathy (RCM), as well as cardiomyopathy (CMP) with a restrictive type of hemodynamics among all cases of genetic CMP and to determine the relative frequencies and spectrum of nucleotide variants in Russian children with RCM, as well as to search...

    Full description

    Get full text
    Article
  12. 12

    EFFECTIVENESS OF MODERN METHODS OF TREATING TYPE I MUCOPOLYSACCHARIDOSIS PATIENTS by L. S. Namazova-Baranova, N. D. Vashakmadze, M. A. Babaikina, E. N. Basargina, N. V. Zhurkova, A. K. Gevorkyan, L. M. Kuzenkova, T. V. Podkletnova, K. V. Zherdev, O. B. Chelpachenko, T. D. Degtyareva

    Published 2014-11-01

    Type I mucopolysaccharidosis (MPS) is a hereditary metabolic disease related to lysosomal storage diseases. Alpha-L-iduronidase enzyme deficiency leads to dissimilar disease phenotypes and varying severity of symptoms. Researchers distinguish between three phenotypes of the disease: Hurler syndrome...

    Full description

    Get full text
    Article
  13. 13

    Nucleotide sequence variant of the TPM1 gene in a family with different phenotypes of left ventricular non-compaction by M. M. Kudryavtseva, A. V. Kiseleva, R. P. Myasnikov, O. V. Kulikova, A. N. Meshkov, E. A. Mershina, R. K. Angarsky, Е. A. Sotnikova, M. G. Divashuk, A. A. Zharikova, S. N. Koretsky, D. A. Filatova, V. E. Sinitsyn, N. A. Sdvigova, V. I. Barsky, E. N. Basargina, O. M. Drapkina

    Published 2023-01-01

    Left ventricular non-compaction (LVNC) is a rare, genetically and phenotypically heterogeneous disease, which is often accompanied by diagnostic difficulties.Aim. To demonstrate several generations of a family with LVNC with various clinical and phenotypic manifestations of the disease (dilated and...

    Full description

    Get full text
    Article
  14. 14

    The combination of left ventricular non-compaction and hypertrophic cardiomyopathy in one family with a pathogenic variant in the MYBPC3 gene (rs397516037) by R. P. Myasnikov, A. V. Kulikova, A. N. Meshkov, E. A. Mershina, A. V. Kiseleva, M. V. Klimushina, M. G. Divashuk, O. V. Kurilova, P. S. Pilyus, M. S. Kharlap, S. N. Koretsky, O. M. Larina, V. E. Sinitsyn, L. A. Gandaeva, V. I. Barsky, E. N. Basargina, S. A. Boytsov, O. M. Drapkina

    Published 2020-11-01

    The article presents the results of clinical, instrumental and molecular genetic tests of three generations of a family with inherited cardiomyopathy caused by a new variant in the MYBPC3 gene. A specific feature of this case is the phenotypic heterogeneity of the mutation — a combination of hypertr...

    Full description

    Get full text
    Article
  15. 15

    Use of Implantable Venous Port Systems in the Treatment of Children with Orphan Diseases (Mucopolysaccharidosis and Pompe Disease): Case Series by M. Yu. Rykov, I. V. Filinov, E. I. Petrov, N. D. Vashakmadze, A. K. Gevorkyan, E. N. Arkhipova, I. V. Sil’nova, E. N. Basargina, N. V. Buchinskaya, A. I. Ivanov, E. A. Isupova, M. M. Kostik, N. A. Abramova, O. V. Kalashnikova, V. G. Chasnyk, A. E. Aleksandrov, D. A. Morozov, V. G. Polyakov

    Published 2015-09-01

    Many orphan diseases in children require life-long and regular intravenous enzyme replacement therapy. The article describes the first Russian practice of implanting venous port systems in 12 patients with type I and II mucopolysaccharidosis and Pompe disease (6 months to 17 years old) to create lon...

    Full description

    Get full text
    Article
  16. 16

    New variant of PRDM16 gene nucleotide sequence in a family with various phenotypic manifestations of the non-compacted myocardium by R. P. Myasnikov, A. A. Bukaeva, O. V. Kulikova, A. I. Ershova, A. V. Petukhova, E. D. Zotova, A. N. Meshkov, E. A. Mershina, A. V. Kiseleva, M. G. Divashuk, P. S. Pilyus, M. S. Kharlap, V. M. Mikova, S. N. Koretsky, L. A. Gandaeva, V. E. Sinitsyn, E.. N. Basargina, S. A. Boytsov, E. A. Snigir, A. I. Akinshina, D. A. Kashtanova, V. V. Makarov, V. S. Yudin, O. M. Drapkina

    Published 2021-04-01

    The article presents the examination of three generations of a family with diagnosed left ventricular noncompaction (LVNC) and various phenotypic manifestations of the disease (isolated, hypertrophic and dilated type of LVNC). As a result of a molecular genetics tests, a previously undescribed singl...

    Full description

    Get full text
    Article